Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Updated Announcement -Metallurgical Test Holes

July 16, 2025

Brunswick Exploration

June 19, 2025

How to Invest in Gene Stocks and ETFs

August 29, 2025

Seymour Concentrate Produces Battery Grade Lithium Hydroxide

August 7, 2025

Crypto Market Update: Bullish Targets Upsized US$4.82 Billion...

August 12, 2025

FPX Nickel Joins Mining Association of Canada and...

August 22, 2025

Charbone Hydrogen Announces Q2 2025 Financial Results

August 30, 2025

Quimbaya Gold Starts Drilling at Tahami South, Testing...

August 9, 2025

Canadian Investment Regulatory Organization Trade Resumption – CYG

June 21, 2025

Strategic EL Secured -Expands Control of NSW Silver...

August 13, 2025